NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients
source: pixabay.com

NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients

According to a recent publication from Express Digest, England's National Health Service (NHS) has reversed its earlier position on a rare disease drug after lengthy public debate, now agreeing to…

Continue Reading NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients
 A New Path to Helping Patients with Rare Diseases 
https://pixabay.com/en/hand-united-together-people-unity-1917895/

 A New Path to Helping Patients with Rare Diseases 

By: Maria Palombini, IEEE-Standards Association  For more than a decade there has been much propaganda on educating and encouraging patients to manage their healthcare. This was a direct shift in response…

Continue Reading  A New Path to Helping Patients with Rare Diseases 
Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant
sasint / Pixabay

Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant

According to a story from mirror.co.uk, a new invention called OrganOx has the potential to make liver transplants more effective and more widely available in the UK. A liver transplant…

Continue Reading Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant
Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
qimono / Pixabay

Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

According to a story from sectorpublishingintelligence.co.uk, studies utilizing data gathered in the real-world treatment setting are highlighting the characteristics of two different therapies for multiple sclerosis (MS) developed by the…

Continue Reading Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C
rawpixel / Pixabay

FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C

According to a story from ir.stockpr.com, the biotechnology company CTD Holdings, Inc., recently announced that the US Food and Drug Administration (FDA) has issued an approval for an individual Investigational…

Continue Reading FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C
Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says
jarmoluk / Pixabay

Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says

According to a story from Healio, the results of a randomized trial suggest that patients with eosinophilic esophagitis are likely to experience rapid relapse if they stop treatment. This was…

Continue Reading Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says
Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug
Pexels / Pixabay

Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug

According to a story from Science Daily, the University of California San Francisco's Benioff Children's Hospitals have successfully treated an infant with juvenile myelomonocytic leukemia. The drug used for treatment…

Continue Reading Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug